Tissue/Organ
Biocybernetics
Organ Growth
Xenotransplantation
3D Bio-printing
Nano
Diagnostic Tools
Micro-surgery
Targeted Delivery
Senescence
Senolytic drugs
Telomeres
Cellular
Mitochondria
Gene editing
Stem Cells
Drugs
Development
Clinical trials
Indication expansion
AI
Diagnosis
Intervention
Digital health
Neural
Neural integration
Singularity
Agetech
Independent living
Diet
Wellness
Longevity finance
Investment
Events
TV
Longevity 2020
Defining biological aging
Rejuvenation therapies
AI & Longevity
Longevity investing
Longevity start now
Free to view
Store
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Newsletter Signup
Basket
Checkout
My account
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Longevity.Technology
Tissue/Organ
All
Biocybernetics
Organ Growth
Xenotransplantation
3D Bio-printing
Wellness
Longevity Escape Velocity within 10 years?
Tissue/Organ
New Buck Institute research is big news for Longevity
Mitochondria
Gut health shines a light on Longevity
Tissue/Organ
Study linking heart health to brain health could delay dementia
Nano
All
Diagnostic Tools
Micro-surgery
Targeted Delivery
Wellness
Longevity Escape Velocity within 10 years?
Nanotech
Nanoparticles to strip away senescent cell defences
Targeted Delivery
Nano drug-delivery system developed for neurological disorders
Investment
Clene goes for gold, and goes public
Senescence
All
Senolytic drugs
Telomeres
Senescence
Clearance of senescent cells for improved cognition
Wellness
Longevity Escape Velocity within 10 years?
Development
AI to quantify senescent cell counts
Senolytic drugs
Senolytic start-up gears up for clinical trials
Cellular
All
Mitochondria
Gene editing
Stem Cells
Mitochondria
Harvard spin-off Cellvie Inc closes $5M seed round
Senescence
Clearance of senescent cells for improved cognition
Cellular
Promising restorative therapy potentially 5 years away
Wellness
Longevity Escape Velocity within 10 years?
Drugs
All
Development
Clinical trials
Indication expansion
Wellness
Proving the Longevity potential of spermidine
Wellness
Longevity Escape Velocity within 10 years?
Cellular
“Adjust the immune system… de-age the brain”
Development
AI to quantify senescent cell counts
AI
All
Diagnosis
Intervention
Digital health
Wellness
Longevity Escape Velocity within 10 years?
Development
AI to quantify senescent cell counts
Investment
Longevity companies to watch in 2021
Development
A year in Longevity: progress perspectives
Neural
All
Neural integration
Singularity
Wellness
Longevity Escape Velocity within 10 years?
Tissue/Organ
Study linking heart health to brain health could delay dementia
Targeted Delivery
Nano drug-delivery system developed for neurological disorders
Wellness
Rise of the superagers – sharp minds and youthful cognition
Agetech
All
Independent living
Diet
Wellness
Longevity finance
Wellness
Going deeper on ketone analysis for longevity
Wellness
Proving the Longevity potential of spermidine
Senescence
Clearance of senescent cells for improved cognition
Wellness
Longevity Escape Velocity within 10 years?
Investment
Events
TV
All
Longevity 2020
Defining biological aging
Rejuvenation therapies
AI & Longevity
Longevity investing
Longevity start now
Free to view
Longevity TV
Investing in the age of Longevity: Investment panel
Longevity TV
Investing in the age of Longevity: Science panel
Investment
Startup Showcase: Rejuvenate Biomed: What do you think?
Longevity TV
Exclusive video interview with Dave Asprey
Store
Longevity TV
The Big Picture: Covid-19 and Longevity investing
Phil Newman
-
April 30, 2020
Longevity TV
The view from the valley
Phil Newman
-
April 30, 2020
Longevity TV
Accelerating agetech
Phil Newman
-
April 30, 2020
Defining biological aging
Rejuvenation therapies
AI & Longevity
Longevity investing
Longevity start now
Longevity investing
Longevity TV
The Juvenescence business model and future of anti-aging
Phil Newman
-
April 30, 2020
0
Greg Bailey, CEO, Juvenescence
Read more
Longevity 2020
Global pandemics & accelerated investment in Longevity
Phil Newman
-
April 30, 2020
0
Dmitry Kaminskiy, Co-founder / Managing Partner, Deep Knowledge Ventures / Longevity.Capital / Deep Knowledge Analytics.
Read more
Longevity TV
The crucial question in Longevity investing: is it repair?
Phil Newman
-
April 30, 2020
0
Reason, Co-founder and CEO, Repair Biotechnologies & Fight Aging!
Read more
Longevity TV
Genome editing: opportunity & anxiety in equal measure
Phil Newman
-
April 30, 2020
0
James Lawford Davies, Partner, Hill Dickinson
Read more
Longevity TV
From science fiction to FDA submission: ectopic organoids & the commercialization of regenerative medicine
Phil Newman
-
April 30, 2020
0
Michael Hufford, Co-Founder and CEO, LyGenesis
Read more
Longevity TV
How to identify new targets and indications for aging drug development
Phil Newman
-
April 30, 2020
0
Simon Melov, Professor, Buck Institute and Founder and CEO, Gerostate Alpha
Read more
Longevity TV
Risk & reward: Longevity investments
Phil Newman
-
April 30, 2020
0
Ronjon Nag, Managing Director and Founder, R42 Group
Read more
Longevity 2020
5 investment lessons from coronavirus
Phil Newman
-
April 30, 2020
0
Sergey Young, Founder, Longevity Vision Fund.
Read more
Longevity TV
‘Longevity investing’ Ask Me Anything
Phil Newman
-
April 30, 2020
0
Various speakers from the conference come together to answer your questions on Longevity investing.
Read more
Latest articles
Going deeper on ketone analysis for longevity
Wellness
Harvard spin-off Cellvie Inc closes $5M seed round
Mitochondria
Proving the Longevity potential of spermidine
Wellness
Clearance of senescent cells for improved cognition
Senescence
Home
Tissue/Organ
Nano
Senescence
Cellular
Drugs
AI
Neural
Agetech
Investment
Newsletter Signup
Events
Longevity TV
Store
Basket
Checkout
My account